The Resistance Crisis: Characterization and Antimicrobial Challenges of Uropathogenic Bacteria
DOI:
https://doi.org/10.70749/ijbr.v3i5.1222Keywords:
Urinary Tract Infections, UTI Patients, Antimicrobial Challenges, Uropathogenic BacteriaAbstract
Urinary tract infections (UTIs) remain a significant clinical challenge, with increasing antibiotic resistance complicating treatment strategies. This cross-sectional study analyzed 124 urine samples from symptomatic UTI patients (84 females, 40 males; mean age 42.5±15.8 years) over a six-month period. Significant bacteriuria (≥10⁵ CFU/mL) was identified in 104 samples (83.9%), which were processed for microbial identification and antibiotic susceptibility testing using standard microbiological techniques and disk diffusion method. Females showed significantly higher UTI prevalence (67.3% vs. 32.7%; χ²=9.83, p=0.002). Gram-negative organisms predominated (87% vs. 13% Gram-positive; χ²=54.15, p<0.001), with Escherichia coli being most prevalent (72%, p<0.001). Carbapenems (meropenem/imipenem) demonstrated 100% susceptibility, while fluoroquinolones exhibited significant resistance (ciprofloxacin 58% vs. moxifloxacin 30%; χ²=12.7, p<0.001). Azithromycin and cefixime showed 10% resistance each. This study highlights the sustained efficacy of carbapenems against uropathogens but reveals concerning resistance to fluoroquinolones, particularly ciprofloxacin. These findings emphasize the need for ongoing antimicrobial surveillance and cautious antibiotic selection in UTI management. This resistance can be reduced by taking precautionary measures like avoiding improper use of antibiotics and self-medication.
Downloads
References
Astal, Z. Y. (2002). Relationship between demographic characteristics and community-acquired urinary tract infection. Eastern Mediterranean Health Journal, 08(01), 164-171.
https://doi.org/10.26719/2002.8.1.164
Bartoletti, R., Cai, T., Wagenlehner, F. M., Naber, K., & Bjerklund Johansen, T. E. (2016). Treatment of urinary tract infections and antibiotic stewardship. European Urology Supplements, 15(4), 81-87.
https://doi.org/10.1016/j.eursup.2016.04.003
Dhillon, S. (2018). Meropenem/Vaborbactam: A review in complicated urinary tract infections. Drugs, 78(12), 1259-1270.
https://doi.org/10.1007/s40265-018-0966-7
Dospinescu, V., Tiele, A., & Covington, J. (2020). Sniffing out urinary tract infection—Diagnosis based on volatile organic compounds and smell profile. Biosensors, 10(8), 83.
https://doi.org/10.3390/bios10080083
El-Sahrigy, S., Shouman, M. G., Ibrahim, H., Rahman, A. A., Habib, S. A., Khattab, A. A., Gomaa, H. A., & Helmy, N. (2019). Prevalence and anti-microbial susceptibility of hospital acquired infections in two pediatric intensive care units in Egypt. Open Access Macedonian Journal of Medical Sciences, 7(11), 1744-1749.
https://doi.org/10.3889/oamjms.2019.485
Faine, B. A., Rech, M. A., Vakkalanka, P., Gross, A., Brown, C., Harding, S. J., Slocum, G., Zimmerman, D., Zepeski, A., Rewitzer, S., Howington, G. T., Campbell, M., Dawson, J., Treu, C. N., Nelson, L., Jones, M., Flack, T., Porter, B., Sarangarm, P., … Talan, D. A. (2022). High prevalence of fluoroquinolone‐resistant UTI among US emergency department patients diagnosed with urinary tract infection, 2018–2020. Academic Emergency Medicine, 29(9), 1096-1105.
https://doi.org/10.1111/acem.14545
Forbes, B. A., Sahm, D. F., & Weissfeld, A. S. (2007). Diagnostic microbiology (pp. 288-302). St Louis: Mosby.
http://sutlib2.sut.ac.th/sut_contents/H109544.pdf
Foxman, B. (2010). The epidemiology of urinary tract infection. Nature Reviews Urology, 7(12), 653-660.
https://doi.org/10.1038/nrurol.2010.190
Foxman, B. (2014). Urinary tract infection syndromes. Infectious Disease Clinics of North America, 28(1), 1-13.
https://doi.org/10.1016/j.idc.2013.09.003
Hudson, P. L., Hung, K. J., Bergerat, A., & Mitchell, C. (2020). Effect of vaginal lactobacillus species on escherichia coli growth. Female Pelvic Medicine & Reconstructive Surgery, 26(2), 146-151.
https://doi.org/10.1097/spv.0000000000000827
JF, M. 2000. Biochemical tests for identification of medical bacteria. Lippinccot, Williams & Williams, Baltimore.
Kaur, R., & Kaur, R. (2020). Symptoms, risk factors, diagnosis and treatment of urinary tract infections. Postgraduate Medical Journal, 97(1154), 803-812.
https://doi.org/10.1136/postgradmedj-2020-139090
Klein, R. D., & Hultgren, S. J. (2020). Urinary tract infections: Microbial pathogenesis, host–pathogen interactions and new treatment strategies. Nature Reviews Microbiology, 18(4), 211-226.
https://doi.org/10.1038/s41579-020-0324-0
Kurts, C., Panzer, U., Anders, H., & Rees, A. J. (2013). The immune system and kidney disease: Basic concepts and clinical implications. Nature Reviews Immunology, 13(10), 738-753.
https://doi.org/10.1038/nri3523
Lo, E., Nicolle, L. E., Coffin, S. E., Gould, C., Maragakis, L. L., Meddings, J., Pegues, D. A., Pettis, A. M., Saint, S., & Yokoe, D. S. (2014). Strategies to prevent catheter-associated urinary tract infections in acute care hospitals: 2014 update. Infection Control & Hospital Epidemiology, 35(5), 464-479.
https://doi.org/10.1086/675718
Mahony, M., McMullan, B., Brown, J., & Kennedy, S. E. (2019). Multidrug-resistant organisms in urinary tract infections in children. Pediatric Nephrology, 35(9), 1563-1573.
https://doi.org/10.1007/s00467-019-04316-5
Medina, M., & Castillo-Pino, E. (2019). An introduction to the epidemiology and burden of urinary tract infections. Therapeutic Advances in Urology, 11.
https://doi.org/10.1177/1756287219832172
Ortega Martell, J. A., Naber, K. G., Milhem Haddad, J., Tirán Saucedo, J., & Domínguez Burgos, J. A. (2019). Prevention of recurrent urinary tract infections: Bridging the gap between clinical practice and guidelines in Latin America. Therapeutic Advances in Urology, 11.
https://doi.org/10.1177/1756287218824089
Rexhepi, M., Besimi, F., Rufati, N., Alili, A., Bajrami, S., & Ismaili, H. (2019). Hospital-based study of maternal, perinatal and neonatal outcomes in adolescent pregnancy compared to adult women pregnancy. Open Access Macedonian Journal of Medical Sciences, 7(5), 760-766.
https://doi.org/10.3889/oamjms.2019.210
Ronald, A. (2002). The etiology of urinary tract infection: Traditional and emerging pathogens. The American Journal of Medicine, 113(1), 14-19.
https://doi.org/10.1016/s0002-9343(02)01055-0
SAID, A., EL-GAMAL, M. S., ABU-ELGHAIT, M., & SALEM, S. (2021). Isolation, identification and antibiotic susceptibility pattern of urinary tract infection bacterial isolates. Letters in Applied NanoBioScience, 10(4), 2820-2830.
https://doi.org/10.33263/lianbs104.28202830
Seifu, W. D., & Gebissa, A. D. (2018). Prevalence and antibiotic susceptibility of Uropathogens from cases of urinary tract infections (UTI) in Shashemene referral hospital, Ethiopia. BMC Infectious Diseases, 18(1).
https://doi.org/10.1186/s12879-017-2911-x
Shetty, N., Tang, J. W., & Andrews, J. (2009). Infectious disease: Pathogenesis, prevention and case studies. John Wiley & Sons.
Tenney, J., Hudson, N., Alnifaidy, H., Li, J. T., & Fung, K. H. (2018). Risk factors for aquiring multidrug-resistant organisms in urinary tract infections: A systematic literature review. Saudi Pharmaceutical Journal, 26(5), 678-684.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research

This work is licensed under a Creative Commons Attribution 4.0 International License.
